Work

Azacytidine Monotherapy in an Infant With Mosaic NRAS ‐Driven Juvenile Myelomonocytic Leukemia

Year: 2025

Type: article

Source: Pediatric Blood & Cancer

DOI: 10.1002/pbc.31647

Authors: Jeremy M. Grenier, Sarah K. Tasian, Elliot Stieglitz, Zied Abdullaev, Gerald B. Wertheim, Marilyn M. Li, Charles A. Phillips

Institutions: Children's Hospital of Philadelphia, University of Pennsylvania, Princess Máxima Center, University of California, San Francisco, UCSF Benioff Children's Hospital, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: Cancer Center Research Training Program, Developmental and Hyperactive Ras Tumor (DHART) SPORE, Implementation of an interventional, risk-adapted clinical trial for children with newly diagnosed juvenile myelomonocytic leukemia.

OpenAlex ID: W4408243935

FWCI:

Cites: 18

Cited by:

Related to: 10